In vitro activity of antifungal agents on yeasts isolated from vaginal secretion

Acta Scientiarum - Health Sciences

Volumn 25, Issue 1, 2003, Pages 51-54

  Falleiros De Pádua, Rubia Andreia ^a   Guilhermetti, Eliana ^a   Estivalet Svidzinski, Terezinha Inez ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antifungal drugs; Candida sp.; Susceptibility test; Vulvovaginal colonization

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; NYSTATIN;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SACCHAROMYCES CEREVISIAE; TORULOPSIS; VAGINA CANDIDIASIS; YEAST;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; SACCHAROMYCES CEREVISIAE; TORULOPSIS;

EID: 23444444315     PISSN: 16799291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BUITRON, G. R. et al. Study on Candida non-albicans species and its correlation to recurrent vulvovaginal candidiais. Ginecol. Obstet. Mex., v. 70, p. 431-436, 2002.
2. GUPTA, A. K.; BLUHM, R. Itraconazole (Sporanox) for vulvovaginal candidiasis. Skin Therapy Lett, v. 7, n. 1, p. 1-3, 2002.
3. HOOG, G. S. Risk assessment of fungi reported from humans and animals. Mycoses, Berlin, v. 39, n. 11/12, p. 407-417, 1996.
4. KURTZMAN, C. P.; FELL, J. W. The Yeast. A taxonomic study. Amsterdam: Elsevier, 1998.
5. KWOK, Y. K. et al. Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore. Int. J. Dermatol., Oxford, v. 37, n. 2, p. 145-149, 1998.
6. LYNCH, M. E.; SOBEL, J. D. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J. Med. Vet. Mycol., v. 32, p. 267-274, 1994.
7. MCGINNI, M. R.; RINALDI, M. G. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids. In: LORIAN, V. (Ed.) Antibiotics in laboratory medicine. Baltimore: Willians & Wilkins, 1991. cap. 7, p.198-257.
8. MILAN, E. P. et al. Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure. Diagn. Microbiol. Infect. Dis., New York, v. 32, p. 211-216, 1998.
9. NCCLS - NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS, Villanova, documento M27-A, v. 17, n. 9, p. 1-28, 1997.
10. NYIRJESY, P. et al. Chronic fungal vaginitis: the value of cultures. Am. J. Obstet. Gynecol., St Louis, v. 173, p. 820-823, 1995.
11. ODDS, F. C. Antifungal therapy. In: KIBBLER, C. C. et al. Principles and practice of clinical mycology. Chichester: Wiley, 1996. cap. 5, p. 35-48.
12. OSSET, J. et al. Papel de lactobacillus como factor protector de la candidiasis vaginal. Med. Clin., Barcelona, v. 117, n. 8, p. 285-288, 2001.
13. REDONDO-LOPEZ, V. et al. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet, Gynecol., Bucharest, v. 76, n. 4, p. 651-655, 1990.
14. REX, J. et al. Antifungal susceptibility testing. Clin. Microbiol. Rev., Washington, DC, v. 6, p. 367-381, 1993.
15. RIBEIRO, M. A. et al. Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia, Dordrecht, v. 151, p. 5-10, 2000.
16. SAPORITI, A. M. et al. Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use. Rev. Argent. Microbiol., Buenos Aires, v. 33, n. 4, p. 217-222, 2001.
17. SOBEL, J. D. Fungal diseases in genitourinary medicine. In: KIBBLER, C. C. et al. Principles and practice of clinical mycology. Chichester: Wiley, 1996. cap. 14, p. 179-199.
18. SOBEL, J. D. Antimicrobial resistance in vulvovaginitis. Curr. Infect. Dis. Rep., v. 3, n. 6, p. 546-549, 2001.
19. TIETZ, H. J. et al. Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicans from Africa. J. Clin. Microbiol., Washington, DC, v. 33, n. 9, p. 2462-2465, 1995.